FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francesco Barchiesi

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Disorders

Physiology

Drug Synergism

Co-author Network

Publications

TOP 3
Elisabetta Spreghini; Arianna Tavanti; Daniele Giannini; Esther Manso; Fiorenza Orlando; Sonia Senesi; Francesco Barchiesi
In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
Massimo Cogliati; Elisabetta Spreghini; Francesco Barchiesi; Anna Maria Tortorano
Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolates.
Elisabetta Spreghini; Daniele Giannini; Esther Manso; Fiorenza Orlando; Brunella Posteraro; Maurizio Sanguinetti; Francesco Barchiesi
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francesco Barchiesi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Elisabetta Spreghini; Arianna Tavanti; Daniele Giannini; Esther Manso; Fiorenza Orlando; Sonia Senesi; Francesco Barchiesi
In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
The Journal of antimicrobial chemotherapy 2012;67(9):2195-202.
2012: Massimo Cogliati; Elisabetta Spreghini; Francesco Barchiesi; Anna Maria Tortorano
Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolates.
Mycopathologia 2012;173(5-6):347-57.
2012: Elisabetta Spreghini; Daniele Giannini; Esther Manso; Fiorenza Orlando; Brunella Posteraro; Maurizio Sanguinetti; Francesco Barchiesi
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.
Antimicrobial agents and chemotherapy 2012;56(3):1215-22.
2010: Krzysztof Kur; Iwona Gabriel; Joachim Morschhäuser; Francesco Barchiesi; Elisabetta Spreghini; Slawomir Milewski
Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulence.
Mycopathologia 2010;170(6):397-402.
2010: Elisabetta Spreghini; Fiorenza Orlando; Daniele Giannini; Francesco Barchiesi
In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
The Journal of antimicrobial chemotherapy 2010;65(10):2158-63.
2009: Oriana Simonetti; G Ganzetti; Daniela Arzeni; Anna Campanati; B Marconi; Carmela Silvestri; Oscar Cirioni; E Gabrielli; I Lenci; Wojciech Kamysz; Elzbieta Kamysz; Andrea Giacometti; Giorgio Scalise; Francesco Barchiesi; Annamaria Offidani
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Peptides 2009;30(10):1794-7.
2009: Elisabetta Spreghini; Fiorenza Orlando; Alfredo Santinelli; Eleonora Pisa; Cristian Loretelli; Esther Manso; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2009;53(9):4035-9.
2009: Francesco Barchiesi; Carmela Silvestri; Daniela Arzeni; Giulia Ganzetti; Sefora Castelletti; Oriana Simonetti; Oscar Cirioni; Wojciech Kamysz; Elzbieta Kamysz; Elisabetta Spreghini; Alessandra Abruzzetti; Alessandra Riva; Annamaria Offidani; Andrea Giacometti; Giorgio Scalise
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47(3):321-6.
2008: Carmelo Massimo Maida; Maria E Milici; Laura Trovato; Salvatore Oliveri; Emanuele Amodio; Elisabetta Spreghini; Giorgio Scalise; Francesco Barchiesi
Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.
Journal of clinical microbiology 2008;46(12):4071-4.
2008: Elisabetta Spreghini; Carmelo Massimo Maida; Serena Tomassetti; Fiorenza Orlando; Daniele Giannini; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Antimicrobial agents and chemotherapy 2008;52(6):1929-33.
2008: Elisabetta Spreghini; Carmelo Massimo Maida; Maria E Milici; Giorgio Scalise; Francesco Barchiesi
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Antimicrobial agents and chemotherapy 2008;52(2):513-7.
2007: Maria E Milici; Carmelo Massimo Maida; Elisabetta Spreghini; Barbara Ravazzolo; Salvatore Oliveri; Giorgio Scalise; Francesco Barchiesi
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.
Journal of clinical microbiology 2007;45(11):3529-33.
2007: Francesco Barchiesi; Andrea Giacometti; Oscar Cirioni; Daniela Arzeni; Wojciech Kamysz; Carmela Silvestri; Alberto Licci; Anna Marigliano; Agnese Della Vittoria; Piotr Nadolski; J Łukasiak; Giorgio Scalise
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
Journal of chemotherapy (Florence, Italy) 2007;19(5):514-8.
2007: Francesco Barchiesi; Andrea Giacometti; Oscar Cirioni; Daniela Arzeni; Carmela Silvestri; Wojciech Kamysz; Alessandra Abbruzzetti; Alessandra Riva; Elzbieta Kamysz; Giorgio Scalise
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Peptides 2007;28(8):1509-13.
2007: Roland Wakieć; Rajendra Prasad; Joachim Morschhäuser; Francesco Barchiesi; Edward Borowski; Slawomir Milewski
Voriconazole and multidrug resistance in Candida albicans.
Mycoses 2007;50(2):109-15.
2007: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniele Giannini; Giorgio Scalise
Caspofungin in combination with amphotericin B against Candida parapsilosis.
Antimicrobial agents and chemotherapy 2007;51(3):941-5.
2007: Francesco Barchiesi; Daniela Arzeni; G Greganti; Anna Marigliano; Serena Tomassetti; Elisabetta Spreghini; Giorgio Scalise
Fluconazole susceptibility of Candida spp. isolates collected over nine years in a teaching hospital of Ancona, Italy.
Journal of chemotherapy (Florence, Italy) 2007;19(1):58-61.
2007: Juan L Rodriguez-Tudela; J Peter Donnelly; Michael A Pfaller; Erja Chryssantou; Peter A Warn; David W Denning; Ana Espinel-Ingroff; Francesco Barchiesi; Manuel Cuenca Estrella
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
Journal of clinical microbiology 2007;45(1):109-11.
2007: Francesco Barchiesi; Elisabetta Spreghini; Alfredo Santinelli; Annette W Fothergill; Eleonora Pisa; Daniele Giannini; Michael G Rinaldi; Giorgio Scalise
Posaconazole prophylaxis in experimental systemic zygomycosis.
Antimicrobial agents and chemotherapy 2007;51(1):73-7.
2006: Maria Bruna Pasticci; Francesco Barchiesi; Stefania Fallani; N Palladino; LM Lapalorcia; M Gubbiotti; M Cozzari; Andrea Novelli; Franco Baldelli
Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report.
Journal of chemotherapy (Florence, Italy) 2006;18(5):549-53.
2006: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Agnese Della Vittoria; Daniela Arzeni; Esther Manso; Giorgio Scalise
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
Antimicrobial agents and chemotherapy 2006;50(8):2719-27.
2006: Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Candida guilliermondii fungemia in patients with hematologic malignancies.
Journal of clinical microbiology 2006;44(7):2458-64.
2006: Wojciech Kamysz; Piotr Nadolski; Anna Kedzia; Oscar Cirioni; Francesco Barchiesi; Andrea Giacometti; Giorgio Scalise; Jerzy Lukasiak; Marcin Okrój
In vitro activity of synthetic antimicrobial peptides against Candida.
Polish journal of microbiology / Polskie Towarzystwo Mikrobiologów = The Polish Society of Microbiologists 2006;55(4):303-7.
2005: Francesco Barchiesi; Elisabetta Spreghini; Alfredo Santinelli; Annette W Fothergill; Stefania Fallani; Esther Manso; Eleonora Pisa; Daniele Giannini; Andrea Novelli; Maria Iris Cassetta; Teresita Mazzei; Michael G Rinaldi; Giorgio Scalise
Efficacy of caspofungin against Aspergillus terreus.
Antimicrobial agents and chemotherapy 2005;49(12):5133-5.
2005: Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniela Arzeni; Daniele Giannini; Giorgio Scalise
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(12):4989-92.
2005: Francesco Barchiesi; Massimo Cogliati; Maria Carmela Esposto; Elisabetta Spreghini; Anna M Schimizzi; Brian L Wickes; Giorgio Scalise; Maria Anna Viviani
Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.
The Journal of infection 2005;51(1):10-6.
2005: Francesco Barchiesi; Elisabetta Spreghini; Annette W Fothergill; Daniela Arzeni; Gianfranco Greganti; Daniele Giannini; Michael G Rinaldi; Giorgio Scalise
Caspofungin in combination with amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(6):2546-9.
2005: Francesco Barchiesi; Anna Maria Tortorano; L Falconi Di Francesco; Anna Lisa Rigoni; Andrea Giacometti; Elisabetta Spreghini; Giorgio Scalise; Maria Anna Viviani
Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.
Journal of medical microbiology 2005;54(Pt 3):279-85.
2004: Francesco Barchiesi; Monia Maracci; Isabella Baldassarri; Elisabetta Spreghini; Daniele Giannini; Giorgio Scalise
Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Diagnostic microbiology and infectious disease 2004;50(3):179-85.
2004: Oriana Simonetti; Maria Luisa Bernardini; Daniela Arzeni; Andreina Cellini; Francesco Barchiesi; Annamaria Offidani
Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years.
Mycopathologia 2004;158(3):271-4.
2004: Francesco Barchiesi; Elisabetta Spreghini; Isabella Baldassarri; Anna Marigliano; Daniela Arzeni; Daniele Giannini; Giorgio Scalise
Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Antimicrobial agents and chemotherapy 2004;48(10):4056-8.
2004: Francesco Barchiesi; Elisabetta Spreghini; Monia Maracci; Annette W Fothergill; Isabella Baldassarri; Michael G Rinaldi; Giorgio Scalise
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Antimicrobial agents and chemotherapy 2004;48(9):3317-22.
2004: Francesco Barchiesi; Elisabetta Spreghini; Anna M Schimizzi; Monia Maracci; Daniele Giannini; Flavia Carle; Giorgio Scalise
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Antimicrobial agents and chemotherapy 2004;48(9):3312-6.
2004: Francesco Barchiesi; Giuseppina Caggiano; L Falconi Di Francesco; Maria Teresa Montagna; Salvatore Barbuti; Giorgio Scalise
Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit.
Diagnostic microbiology and infectious disease 2004;49(4):269-71.
2003: Manuel Cuenca Estrella; C B Moore; Francesco Barchiesi; J Bille; E Chryssanthou; David W Denning; J Peter Donnelly; F Dromer; B Dupont; J H Rex; MALCOLM RICHARDSON; B Sancak; P E Verweij; Juan Luis Rodríguez Tudela
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(6):467-74.
2003: Francesco Barchiesi; Giuseppina Caggiano; Monia Maracci; Daniela Arzeni; Giorgio Scalise; Maria Teresa Montagna
Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.
The Journal of antimicrobial chemotherapy 2003;51(2):431-3.
2003: Francesco Barchiesi; Maria E Milici; Daniela Arzeni; Anna M Schimizzi; Giuseppe Pizzo; Giovanni M Giammanco; Daniele Giannini; Marco Manfrini; Giorgio Scalise; Chiara B Vicentini
In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.
The Journal of antimicrobial chemotherapy 2003;51(1):167-70.
2002: Francesco Barchiesi; Monia Maracci; Brunella Radi; Daniela Arzeni; Isabella Baldassarri; Andrea Giacometti; Giorgio Scalise
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2002;50(6):999-1002.
2002: Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Franciszek Kasprzykowski; Francesco Barchiesi; Maria Simona Del Prete; Zbigniew Maćkiewicz; Giorgio Scalise
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity.
Peptides 2002;23(5):1015-8.
2002: Giuseppe Pizzo; Francesco Barchiesi; L Falconi Di Francesco; Giovanna Giuliana; Daniela Arzeni; Maria E Milici; Matteo D'Angelo; Giorgio Scalise
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Archives of oral biology 2002;47(3):189-96.
2001: Francesco Barchiesi; Anna M Schimizzi; F Caselli; Daniele Giannini; V Camiletti; B Fileni; Andrea Giacometti; L Falconi Di Francesco; Giorgio Scalise
Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 2001;48(6):769-73.
2001: Francesco Barchiesi; Daniela Arzeni; V Camiletti; Oriana Simonetti; Andreina Cellini; Annamaria Offidani; Giorgio Scalise
In vitro activity of posaconazole against clinical isolates of dermatophytes.
Journal of clinical microbiology 2001;39(11):4208-9.
2001: Francesco Barchiesi; Anna M Schimizzi; Laura K Najvar; Rosie Bocanegra; F Caselli; S Di Cesare; Daniele Giannini; L Falconi Di Francesco; Andrea Giacometti; Flavia Carle; Giorgio Scalise; John Graybill
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2001;45(5):1355-9.
2001: Francesco Barchiesi; L Falconi Di Francesco; Daniela Arzeni; F Caselli; Oriana Simonetti; Andreina Cellini; Andrea Giacometti; Annamaria Offidani; Giorgio Scalise
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.
Mycopathologia 2001;149(3):117-21.
2001: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Anna Fineo; Giorgio Scalise
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2001;47(1):97-9.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; Giorgio Scalise
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.
Antimicrobial agents and chemotherapy 2000;44(12):3473-5.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; Aldo Paggi; E Petrelli; Giorgio Scalise
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
The Journal of antimicrobial chemotherapy 2000;46(5):807-10.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Giorgio Scalise
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Diagnostic microbiology and infectious disease 2000;38(2):115-8.
2000: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
The Journal of antimicrobial chemotherapy 2000;46(4):577-82.
2000: Francesco Barchiesi; Anna M Schimizzi; F Caselli; Andrea Novelli; Stefania Fallani; Daniele Giannini; Daniela Arzeni; S Di Cesare; L Falconi Di Francesco; M Fortuna; Andrea Giacometti; Flavia Carle; Teresita Mazzei; Giorgio Scalise
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2000;44(9):2435-41.
2000: Anna Maria Tortorano; Francesco Barchiesi; Esther Manso; M T Montagna; C Farina; L Ferrari; A Raballo; A Grancini; G Lombardi
Is a kit for identification of clinical yeasts correctly evaluated when released onto the market?
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(7):567-9.
2000: Andrea Giacometti; Oscar Cirioni; Maria Simona Del Prete; Francesco Barchiesi; M Fortuna; D Drenaggi; Giorgio Scalise
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.
Antimicrobial agents and chemotherapy 2000;44(6):1716-9.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Maria Simona Del Prete; M Fortuna; F Caselli; Giorgio Scalise
In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically.
Antimicrobial agents and chemotherapy 2000;44(6):1694-6.
2000: Francesco Barchiesi; D Calabrese; Dominique Sanglard; L Falconi Di Francesco; F Caselli; Daniele Giannini; Andrea Giacometti; S Gavaudan; Giorgio Scalise
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750.
Antimicrobial agents and chemotherapy 2000;44(6):1578-84.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems.
The Journal of antimicrobial chemotherapy 2000;45(5):651-4.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2000;45(4):453-6.
2000: Francesco Barchiesi; Daniela Arzeni; F Caselli; Giorgio Scalise
Primary resistance to flucytosine among clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 2000;45(3):408-9.
2000: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Giorgio Scalise
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.
The Journal of antimicrobial chemotherapy 2000;45(3):375-7.
2000: Andrea Giacometti; Oscar Cirioni; Anna M Schimizzi; Maria Simona Del Prete; Francesco Barchiesi; MM D'Errico; E Petrelli; Giorgio Scalise
Epidemiology and microbiology of surgical wound infections.
Journal of clinical microbiology 2000;38(2):918-22.
2000: L Lamura; Ruth C Matthews; Francesco Barchiesi; M Donahoe; James Burnie; Giorgio Scalise
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
The Journal of infection 2000;40(1):64-8.
2000: Francesco Barchiesi; Daniela Arzeni; Annette W Fothergill; L Falconi Di Francesco; F Caselli; Michael G Rinaldi; Giorgio Scalise
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.
Antimicrobial agents and chemotherapy 2000;44(1):226-9.
1999: Andrea Giacometti; F Burzacchini; Oscar Cirioni; Francesco Barchiesi; M Dini; Giorgio Scalise
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(12):885-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(11):827-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; Maria Simona Del Prete; Giorgio Scalise
Antimicrobial activity of polycationic peptides.
Peptides 1999;20(11):1265-73.
1999: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1999;44(5):653-9.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; M Fortuna; Giorgio Scalise
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1999;44(5):641-5.
1999: L Falconi Di Francesco; Francesco Barchiesi; F Caselli; Oscar Cirioni; Giorgio Scalise
Comparison of four methods for DNA typing of clinical isolates of Candida glabrata.
Journal of medical microbiology 1999;48(10):955-63.
1999: Andrea Giacometti; Oscar Cirioni; Francesco Barchiesi; F Caselli; Giorgio Scalise
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates.
The Journal of antimicrobial chemotherapy 1999;44(3):403-6.
1999: Francesco Barchiesi; D Gallo; F Caselli; L Falconi Di Francesco; Daniela Arzeni; Andrea Giacometti; Giorgio Scalise
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1999;44(1):65-70.
1999: alessandro scalise; Francesco Barchiesi; Maria Anna Viviani; Daniela Arzeni; Aldo Bertani; Giorgio Scalise
Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot.
The Journal of infection 1999;38(3):191-2.
1999: Francesco Barchiesi; Anna M Schimizzi; Annette W Fothergill; Giorgio Scalise; M G Rinaldi
In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(4):302-4.
1999: Francesco Barchiesi; L Falconi Di Francesco; Daniela Arzeni; F Caselli; D Gallo; Giorgio Scalise
Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(3):184-7.
1999: Francesco Barchiesi; Anna Maria Tortorano; L Falconi Di Francesco; Massimo Cogliati; Giorgio Scalise; Maria Anna Viviani
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 1999;43(2):295-9.
1998: Francesco Barchiesi; Daniela Arzeni; P Compagnucci; L Falconi Di Francesco; Andrea Giacometti; Giorgio Scalise
In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(6):437-40.
1998: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(4):445-51.
1998: Daniela Arzeni; Francesco Barchiesi; P Compagnucci; Andreina Cellini; Oriana Simonetti; Annamaria Offidani; Giorgio Scalise
In vitro activity of terbinafine against clinical isolates of dermatophytes.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(4):235-7.
1998: Oscar Cirioni; Andrea Giacometti; Francesco Barchiesi; Giorgio Scalise
In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(2):141-5.
1998: Anna Maria Tortorano; Maria Anna Viviani; Francesco Barchiesi; Daniela Arzeni; Anna Lisa Rigoni; Massimo Cogliati; P Compagnucci; Giorgio Scalise
Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Journal of clinical microbiology 1998;36(6):1578-83.
1998: Francesco Barchiesi; Daniela Arzeni; M S Del Prete; A Sinicco; L Falconi Di Francesco; Maria Bruna Pasticci; L Lamura; M M Nuzzo; F Burzacchini; S Coppola; F Chiodo; Giorgio Scalise
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
The Journal of antimicrobial chemotherapy 1998;41(5):541-8.
1998: Francesco Barchiesi; L Falconi Di Francesco; P Compagnucci; Daniela Arzeni; Andrea Giacometti; Giorgio Scalise
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
The Journal of antimicrobial chemotherapy 1998;41(1):59-65.
1997: Francesco Barchiesi; L Falconi Di Francesco; P Compagnucci; Daniela Arzeni; Oscar Cirioni; Giorgio Scalise
Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(8):601-5.
1997: Francesco Barchiesi; L Falconi Di Francesco; Giorgio Scalise
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Antimicrobial agents and chemotherapy 1997;41(8):1812-4.
1996: Francesco Barchiesi; Laura K Najvar; MF Luther; G Scalise; Michael G Rinaldi; John Graybill
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
Antimicrobial agents and chemotherapy 1996;40(5):1317-20.
1995: Francesco Barchiesi; Richard J Hollis; S A Messer; G Scalise; Michael G Rinaldi; Michael A Pfaller
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.
Diagnostic microbiology and infectious disease 1995;23(3):99-103.
1995: Francesco Barchiesi; Richard J Hollis; Maurizio Del Poeta; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):561-4.
1995: M H Nguyen; Francesco Barchiesi; D A McGough; Victor L Yu; Michael G Rinaldi
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans.
Antimicrobial agents and chemotherapy 1995;39(8):1691-5.
1995: A L Colombo; Francesco Barchiesi; D A McGough; A W Fothergill; Michael G Rinaldi
Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.
The Journal of antimicrobial chemotherapy 1995;36(1):93-100.
1995: Francesco Barchiesi; Richard J Hollis; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):634-40.
1995: A L Colombo; Francesco Barchiesi; D A McGough; Michael G Rinaldi
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Journal of clinical microbiology 1995;33(3):535-40.
1994: Francesco Barchiesi; A L Colombo; D A McGough; A W Fothergill; Michael G Rinaldi
In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1994;38(11):2553-6.
1994: Maurizio Del Poeta; Francesco Barchiesi; Daniela Arzeni; G Marinucci; Giorgio Scalise
Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.
Mycoses 1994;37(11-12):411-6.
1994: Francesco Barchiesi; A L Colombo; D A McGough; Michael G Rinaldi
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
Journal of clinical microbiology 1994;32(10):2494-500.
1994: Francesco Barchiesi; A L Colombo; D A McGough; A W Fothergill; Michael G Rinaldi
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1994;38(7):1530-3.
1994: Maurizio Del Poeta; Francesco Barchiesi; V Morbiducci; Daniela Arzeni; G Marinucci; F Ancarani; Giorgio Scalise
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Journal of chemotherapy (Florence, Italy) 1994;6(3):173-6.
1994: Francesco Barchiesi; Maurizio Del Poeta; V Morbiducci; F Ancarani; Giorgio Scalise
Effect of pentamidine on the growth of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1994;33(6):1229-32.
1993: Francesco Barchiesi; Maurizio Del Poeta; V Morbiducci; F Ancarani; Giorgio Scalise
Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.
Mycopathologia 1993;124(1):19-25.
1993: Francesco Barchiesi; V Morbiducci; F Ancarani; Giorgio Scalise
Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.
European journal of epidemiology 1993;9(4):455-6.
1993: Francesco Barchiesi; V Morbiducci; F Ancarani; Daniela Arzeni; Giorgio Scalise
Trichosporon beigelii fungaemia in an AIDS patient.
AIDS (London, England) 1993;7(1):139-40.
1992: Francesco Barchiesi; Andrea Giacometti; Daniela Arzeni; P Branchesi; G Crescenzi; F Ancarani; Giorgio Scalise
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Journal of chemotherapy (Florence, Italy) 1992;4(6):381-6.
1991: Daniela Arzeni; Francesco Barchiesi; F Ancarani; Giorgio Scalise
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Journal of chemotherapy (Florence, Italy) 1991;3(3):139-42.